Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model

By sjmartinez • April 5, 2023

Zhang P, Miyata KN, Nast CC, LaPage JA, Mahoney M, Nguyen S, Khan K, Wu Q, Adler SG, Dai T. Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model. Perit Dial Int. 2023 Mar;43(2):159-167. doi: 10.1177/08968608221116956. Epub 2022 Aug 9. PMID: 35946050.

Tags: Angiogenesis, fibrosis, Harbor UCLA, JAK inhibitor, Nephrology, peritoneal dialysis, peritoneal membrane, Publications

Topological Data Analysis in the Assessment of Coronary Atherosclerosis: A Comprehensive Narrative Review

Singh Y, Hathaway QA, Farrelly C, Budoff MJ, Erickson B, Collins JD, Blaha MJ, Leiner T, Lopez-Jimenez F, Rozenblit J, Sarkar D, Carlsson G. Topological[...]

Coronary Artery Bypass Grafting Is Rarely Done in the Acute Care of ST-elevation Myocardial Infarction Patients Treated by Emergency Medical Services

Toy J, Lauer C, Kaji AH, Thomas JL, Megowan N, Bosson N, Gausche-Hill M, Dhawan P, Kloner RA, Rasnake S, French W, Schlesinger S. Coronary[...]

Host targets of candidalysin

Lin J, Filler SG. Host targets of candidalysin. PLoS Pathog. 2025 Jun 23;21(6):e1013284. doi: 10.1371/journal.ppat.1013284. PMID: 40549807; PMCID: PMC12184922.